Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti PD-1”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05468294
What this trial is testing

F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Philogen S.p.A. 3
Testing effectiveness (Phase 2)Study completedNCT03161379
What this trial is testing

GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Testing effectiveness (Phase 2)Ended earlyNCT03721679
What this trial is testing

Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1

Who this might be right for
Solid Cancer
Oncovir, Inc. 7
Early research (Phase 1)UnknownNCT05442996
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor, Adult
Shanghai Henlius Biotech 30
Large-scale testing (Phase 3)UnknownNCT04033354
What this trial is testing

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Who this might be right for
Squamous Non Small Cell Lung Cancer
Shanghai Henlius Biotech 537
Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Early research (Phase 1)Ended earlyNCT05904496
What this trial is testing

BGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeiGene 44
Testing effectiveness (Phase 2)Ended earlyNCT04936841
What this trial is testing

Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
University of Wisconsin, Madison 5
Early research (Phase 1)Ended earlyNCT03843359
What this trial is testing

A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 97
Not applicableUnknownNCT05288569
What this trial is testing

IrAE Prediction of Anti-PD-1/L1 in Lung Cancer

Who this might be right for
Immune Checkpoint InhibitorsLung Cancer
Peking Union Medical College Hospital 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03970746
What this trial is testing

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

Who this might be right for
Non Small Cell Lung Cancer
PDC*line Pharma SAS 73
Not applicableStudy completedNCT04793815
What this trial is testing

Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)

Who this might be right for
Non-small Cell Lung Cancer MetastaticCryotherapy Effect
Centre hospitalier de l'Université de Montréal (CHUM) 15
Early research (Phase 1)Study completedNCT03817125
What this trial is testing

Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention

Who this might be right for
Metastatic Melanoma
Parker Institute for Cancer Immunotherapy 14
Testing effectiveness (Phase 2)Study completedNCT03639935
What this trial is testing

Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

Who this might be right for
Biliary Tract Cancer
University of Michigan Rogel Cancer Center 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07762716
What this trial is testing

Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy

Who this might be right for
Glioblastoma (GBM)
BreakBio Corp 10
Testing effectiveness (Phase 2)Ended earlyNCT04131634
What this trial is testing

Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer

Who this might be right for
Urothelial Cancer
University of Texas Southwestern Medical Center 2
Testing effectiveness (Phase 2)Ended earlyNCT03585465
What this trial is testing

Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors

Who this might be right for
Childhood Solid Tumor
Centre Oscar Lambret 63
Large-scale testing (Phase 3)WithdrawnNCT04203511
What this trial is testing

INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301)

Who this might be right for
Non-small Cell Lung Cancer
Incyte Corporation
Testing effectiveness (Phase 2)Study completedNCT02598960
What this trial is testing

An Investigational Immuno-therapy Study of Experimental Medication BMS-986156, Given by Itself or in Combination With Nivolumab in Patients With Solid Cancers or Cancers That Have Spread.

Who this might be right for
Solid Tumors
Bristol-Myers Squibb 295
Post-approval studies (Phase 4)Temporarily pausedNCT04036721
What this trial is testing

Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis

Who this might be right for
Lung Neoplasm MalignantInterstitial Lung Disease
National Institute for Tuberculosis and Lung Diseases, Poland 85
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation